Back to Blog
Featured Blog

Cell Therapy vs Gene Therapy: What's the Difference?

Both cell therapy and gene therapy are biomedical treatments that aim to treat, prevent and ultimately cure diseases by targeting them at a cellular level. This blog will explore the key differences between the two therapies including their different approaches, mechanisms and characteristics so that you can decide if working in gene and cell therapy is right for you. 

 

What Is Cell Therapy?

Cell therapy is the transfer of intact, live cells into a patient to help replace or repair damaged cells caused by disease. These cells can be modified or cultivated outside the body and can come from either the patient themselves (autologous cells) or a donor (allogeneic cells).  Common cells used in cell therapy include stem cells, immune cells and progenitor cells.

By replacing and repairing lost and dysfunctional cells, cell therapy stimulates the body’s own repair mechanisms and enhances immune responses. This can be particularly useful when used to treat degenerative conditions and certain cancers like leukaemia.

 

What Is Gene Therapy?

Gene therapy focuses on the genetic basis of diseases and involves transferring genetic material into a patient’s cells, either inside (in vivo) or outside (ex vivo) the body. This genetic material can be used to replace, inactivate, or introduce new genes. By correcting genetic defects, gene therapy aims to produce a therapeutic effect at the molecular level, leading to long-lasting changes in how cells function.

Gene therapy is particularly relevant in the treatment of inherited conditions like cystic fibrosis and haemophilia alongside some cancers and viral infections. However, almost every gene in the human genome can be targeted, so the potential for new therapies is immense.

 

Key Differences Between Cell and Gene Therapy

While both therapies aim to improve patient outcomes through cellular and molecular interventions, they differ in both their approach and execution.

  • Cell therapy concentrates on replacing and repairing cells, whereas gene therapy targets the genetic material within those cells.

  • Cell therapy often involves direct cellular administration, whereas gene therapy uses vectors (like viruses) to deliver genetic material into the cells.

  • Although the diseases targeted by each therapy can overlap, gene therapy is often used for genetic disorders, whereas cell therapy mainly focuses on regenerative medicine and oncology.

 

Despite their differences, cell and gene therapy are complementary techniques that are often used together for the treatment of many diseases. For example, cell-based gene therapy involves cells being removed from the patient, altered using gene therapy and then implanted back into the patient’s body.

So, although different in their mechanisms, cell and gene therapy are united in their aims and applications in therapeutics. Thanks to continuous advancements across the board in these fields, cell and gene therapy are quickly becoming two of the most influential tools in the treatment of age-related and genetic disorders and have the potential to completely transform the way we approach and treat illness.

Share this Article

Relocating to the US for your pharmaceutical career

If you'll be relocating to the US from another country, you may need a work visa.

The specific type of visa you need will depend on your country of origin, the company's needs and whether the employment is permanent or a temporary assignment. Your prospective employer will discuss this with you.

If you're looking for a career in the pharma industry, HRS can help! We work with top pharmaceutical employers on both sides of the Atlantic to find the right people for a range of different roles. Use the links below to browse the latest vacancies, or enquire now for more information.

Job SearchContact us